This page shows the latest Argos Therapeutics news and features for those working in and with pharma, biotech and healthcare.
It currently has around 25 companies in its portfolio, including Dutch gene therapy specialist UniQure, UK women’s health start-up KaNDy Therapeutics and US biotech Argos Therapeutics which as an
Argos Therapeutics' hopes of bringing lead cancer immunotherapy rocapuldencel-T to market anytime soon have been dashed after it flunked a pivotal phase III trial. ... Shares in Argos lost two-thirds of their value after the news broke as investors grew
Last year for example, Boehringer Ingelheim licensed rights to CureVac's investigational therapeutic cancer vaccine CV9202 - which it plans to test alongside its Giotrif (afatinib) product - while Argos Therapeutics and Northwest
AGS 003 consists of dendritic cells that have been loaded with whole tumour RNA using Argos Therapeutics' proprietary Arcelis Personalised Immunotherapy Platform.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...